Proteome Sciences PLC - London-based protein-focused drug development services provider - Completes installation and setup of equipment in its new lab in San Diego, California. The lab is now fully operational. Back in May, Proteome had announced it was expanding its proteomics services to the US. Says that the lab is "well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes".
Proteome Sciences US Inc President Ian Pike says: "I am delighted that we are able to open our doors to serve arguably the world's largest biotechnology hub in California. Providing easier access to our US customers and with innovations including TMTpro 32plex and single cell proteomics, delivered from both our dedicated laboratories in the US and Europe we are well set to continue our leading role in provision of tools, assays and services in proteomics research as it grows in importance to enhance pharmaceutical research and drug development."
Current stock price: 5.45 pence
12-month change: up 50%
By Sabrina Penty, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Proteome (PRM)